Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca2+ channels in the embryonic heart of mice

Access this Article

Author(s)

    • Mizuta Einosuke
    • Division of Molecular Medicine and Therapeutics, Department of Multidisciplinary Internal Medicine, Tottori University Faculty of Medicine
    • Hisatome Ichiro
    • Department of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science
    • Morisaki Takayuki
    • Department of Bioscience, National Cardiovascular Center Research Institute
    • Shirai Manabu
    • Department of Bioscience, National Cardiovascular Center Research Institute
    • Arakawa Keita
    • Department of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science
    • Hidaka Kyoko
    • Department of Bioscience, National Cardiovascular Center Research Institute
    • Miake Junichiro
    • Division of Molecular Medicine and Therapeutics, Department of Multidisciplinary Internal Medicine, Tottori University Faculty of Medicine
    • Ninomiya Haruaki
    • Department of Biological Regulation, Tottori University Faculty of Medicine
    • Kato Masahiko
    • Division of Molecular Medicine and Therapeutics, Department of Multidisciplinary Internal Medicine, Tottori University Faculty of Medicine
    • Shigemasa Chiaki
    • Division of Molecular Medicine and Therapeutics, Department of Multidisciplinary Internal Medicine, Tottori University Faculty of Medicine
    • Shirayoshi Yasuaki
    • Department of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science

Abstract

We investigated the distribution of T-type Ca<SUP>2+</SUP> channel mRNAs in the mouse embryonic heart. <I>Cav3.2</I>, but not <I>Cav3.1</I>, was expressed in the E8.5 embryonic heart along with cardiac progenitor markers (<I>Nkx2.5</I>, <I>Tbx5</I>, <I>Isl-1</I>) and contractile proteins (<I>alpha</I> and <I>beta MHC</I>). In the E10.5 heart, the distribution of <I>Cav3.1</I> mRNA was confirmed in the AV-canal and overlapped with that of <I>MinK</I> or <I>Tbx2</I>. <I>Cav3.2</I> mRNA was observed not only in the AV-canal but also in the outflow tract, along with <I>MinK</I> and <I>Isl-1</I>, indicating the expression of <I>Cav3.2</I> in the secondary heart field. Thus, <I>Cav3.2</I> may contribute to the development of the outflow tract from the secondary heart field in the embryonic heart, whereas <I>Cav3.1</I> may be involved in the development of the cardiac conduction-system together with <I>Cav3.2</I>.

Journal

  • Biomedical Research

    Biomedical Research 31(5), 301-305, 2010

    Biomedical Research Press

Codes

Page Top